Crinetics Pharmaceuticals Stock Market Value
| CRNX Stock | USD 57.03 0.96 1.71% |
| Symbol | Crinetics |
Crinetics Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Crinetics Pharmaceuticals. If investors know Crinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Crinetics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.70) | Revenue Per Share 0.014 | Quarterly Revenue Growth (0.60) | Return On Assets (0.24) | Return On Equity (0.40) |
The market value of Crinetics Pharmaceuticals is measured differently than its book value, which is the value of Crinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Crinetics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Crinetics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Crinetics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Crinetics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Crinetics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Crinetics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Crinetics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Crinetics Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Crinetics Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Crinetics Pharmaceuticals.
| 05/26/2024 |
| 11/22/2024 |
If you would invest 0.00 in Crinetics Pharmaceuticals on May 26, 2024 and sell it all today you would earn a total of 0.00 from holding Crinetics Pharmaceuticals or generate 0.0% return on investment in Crinetics Pharmaceuticals over 180 days. Crinetics Pharmaceuticals is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and com... More
Crinetics Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Crinetics Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Crinetics Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.53 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 3.67 |
Crinetics Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Crinetics Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Crinetics Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Crinetics Pharmaceuticals historical prices to predict the future Crinetics Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0352 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0833 |
Crinetics Pharmaceuticals Backtested Returns
At this stage we consider Crinetics Stock to be very steady. Crinetics Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0582, which signifies that the company had a 0.0582% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Crinetics Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Crinetics Pharmaceuticals' Risk Adjusted Performance of 0.0352, mean deviation of 1.69, and Downside Deviation of 2.53 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%. Crinetics Pharmaceuticals has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Crinetics Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Crinetics Pharmaceuticals is expected to follow. Crinetics Pharmaceuticals right now shows a risk of 2.44%. Please confirm Crinetics Pharmaceuticals sortino ratio, as well as the relationship between the semi variance and rate of daily change , to decide if Crinetics Pharmaceuticals will be following its price patterns.
Auto-correlation | 0.61 |
Good predictability
Crinetics Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Crinetics Pharmaceuticals time series from 26th of May 2024 to 24th of August 2024 and 24th of August 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Crinetics Pharmaceuticals price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Crinetics Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 10.06 |
Crinetics Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Crinetics Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Crinetics Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Crinetics Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Crinetics Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Crinetics Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Crinetics Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Crinetics Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Crinetics Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Crinetics Pharmaceuticals Lagged Returns
When evaluating Crinetics Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Crinetics Pharmaceuticals stock have on its future price. Crinetics Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Crinetics Pharmaceuticals autocorrelation shows the relationship between Crinetics Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Crinetics Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Crinetics Stock Analysis
When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.